COVID-19 – Day 125: FDA Approves Cepheid 45 mns SARS-Cov2 Test for Hospitals

XPERT_SARS-COV_2

(E) Cepheid, a  company which provides automated molecular diagnostics through its GeneXpert® System for hospitals has announced a new test approved by the FDA for Covid-19 that can be performed in less than 45 mns by any hospital using the GeneXpert. Following is the press release  Xpert® Xpress SARS-CoV-2 has received FDA Emergency Use Authorization, and a video from its Chief Medical Officer’s David Persing:

 

 

Note: The picture above is the Xpert Xpress from Cepheid.

Copyright © 2005-2020 by Serge-Paul Carrasco. All rights reserved.
Contact Us: asvinsider at gmail dot com

Categories: Coronavirus